BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 12673954)

  • 1. Adult bacteremic pneumococcal pneumonia acquired in the community. A prospective study on 101 patients.
    Gentile JH; Sparo MD; Mercapide ME; Luna CM
    Medicina (B Aires); 2003; 63(1):9-14. PubMed ID: 12673954
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Current use of penicillin in community-acquired pneumococcal pneumonias].
    Gaztelurrutia L; Zalacaín R; Rubio G; Hernández JL; Urra E; Hernández M; Garea C; Barrón J
    Enferm Infecc Microbiol Clin; 1994 Jan; 12(1):17-20. PubMed ID: 8155749
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Penicillin-resistant pneumococci and the empirical use of penicillins in the treatment of community-acquired acute pneumonia].
    Sánchez C; Armengol R; Mir I; Lite J; Garau J
    Enferm Infecc Microbiol Clin; 1992; 10(6):334-9. PubMed ID: 1391015
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Risk factors and clinical outcomes of penicillin resistant S. pneumoniae community-acquired pneumonia in Khon Kaen, Thailand.
    Reechaipichitkul W; Assawasanti K; Chaimanee P
    Southeast Asian J Trop Med Public Health; 2006 Mar; 37(2):320-6. PubMed ID: 17124993
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Resistance to penicillin and cephalosporin and mortality from severe pneumococcal pneumonia in Barcelona, Spain.
    Pallares R; Liñares J; Vadillo M; Cabellos C; Manresa F; Viladrich PF; Martin R; Gudiol F
    N Engl J Med; 1995 Aug; 333(8):474-80. PubMed ID: 7623879
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Community acquired pneumococcal pneumonia in hospitalized adult patients].
    Díaz A; Torres C; Flores LJ; García P; Saldías F
    Rev Med Chil; 2003 May; 131(5):505-14. PubMed ID: 12879811
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A comparative study of bacteremic and non-bacteremic pneumococcal pneumonia.
    Jover F; Cuadrado JM; Andreu L; Martínez S; Cañizares R; de la Tabla VO; Martin C; Roig P; Merino J
    Eur J Intern Med; 2008 Jan; 19(1):15-21. PubMed ID: 18206596
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Community-acquired bacteraemic pneumococcal pneumonia in adults: effect of diminished penicillin susceptibility on clinical outcome.
    Bonnard P; Lescure FX; Douadi Y; Schmit JL; Jounieaux V; Laurans G; Eb F; Ducroix JP
    J Infect; 2005 Jul; 51(1):69-76. PubMed ID: 15979494
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adult bacteremic pneumococcal pneumonia in a community teaching hospital, 1992-1996. A detailed analysis of 108 cases.
    Watanakunakorn C; Bailey TA
    Arch Intern Med; 1997 Sep; 157(17):1965-71. PubMed ID: 9308508
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Severity scoring in community-acquired pneumonia caused by Streptococcus pneumoniae: a 5-year experience.
    Ioachimescu OC; Ioachimescu AG; Iannini PB
    Int J Antimicrob Agents; 2004 Nov; 24(5):485-90. PubMed ID: 15519482
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical outcomes of pneumococcal pneumonia caused by antibiotic-resistant strains in asian countries: a study by the Asian Network for Surveillance of Resistant Pathogens.
    Song JH; Jung SI; Ki HK; Shin MH; Ko KS; Son JS; Chang HH; Kim SW; Lee H; Kim YS; Oh WS; Peck KR; Chongthaleong A; Lalitha MK; Perera J; Yee TT; Jamal F; Kamarulzaman A; Carlos CC; So T;
    Clin Infect Dis; 2004 Jun; 38(11):1570-8. PubMed ID: 15156445
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Influence of penicillin resistance on outcome in adult patients with invasive pneumococcal pneumonia: is penicillin useful against intermediately resistant strains?
    Falcó V; Almirante B; Jordano Q; Calonge L; del Valle O; Pigrau C; Planes AM; Gavaldà J; Pahissa A
    J Antimicrob Chemother; 2004 Aug; 54(2):481-8. PubMed ID: 15215226
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pulmonary complications of pneumococcal community-acquired pneumonia: incidence, predictors, and outcomes.
    Cillóniz C; Ewig S; Polverino E; Muñoz-Almagro C; Marco F; Gabarrús A; Menéndez R; Mensa J; Torres A
    Clin Microbiol Infect; 2012 Nov; 18(11):1134-42. PubMed ID: 22044658
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Radiographic, clinical, and prognostic features of complicated and uncomplicated community-acquired lobar pneumonia in children.
    Lin CJ; Chen PY; Huang FL; Lee T; Chi CS; Lin CY
    J Microbiol Immunol Infect; 2006 Dec; 39(6):489-95. PubMed ID: 17164952
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Drug-resistant pneumococcal pneumonia: clinical relevance and related factors.
    Aspa J; Rajas O; Rodríguez de Castro F; Blanquer J; Zalacain R; Fenoll A; de Celis R; Vargas A; Rodríguez Salvanés F; España PP; Rello J; Torres A;
    Clin Infect Dis; 2004 Mar; 38(6):787-98. PubMed ID: 14999620
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of penicillin susceptibility on medical outcomes for adult patients with bacteremic pneumococcal pneumonia.
    Metlay JP; Hofmann J; Cetron MS; Fine MJ; Farley MM; Whitney C; Breiman RF
    Clin Infect Dis; 2000 Mar; 30(3):520-8. PubMed ID: 10722438
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy and safety of twice-daily pharmacokinetically enhanced amoxicillin/clavulanate (2000/125 mg) in the treatment of adults with community-acquired pneumonia in a country with a high prevalence of penicillin-resistant Streptococcus pneumoniae.
    Siquier B; Sánchez-Alvarez J; García-Mendez E; Sabriá M; Santos J; Pallarés R; Twynholm M; Dal-Ré R;
    J Antimicrob Chemother; 2006 Mar; 57(3):536-45. PubMed ID: 16446376
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Community-acquired bacteremic pneumococcal pneumonia. Effect of age on manifestations and outcome.
    Esposito AL
    Arch Intern Med; 1984 May; 144(5):945-8. PubMed ID: 6712411
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antimicrobial susceptibility of Streptococcus pneumoniae isolated from patients with respiratory tract infections in Thailand.
    Srifuengfung S; Tribuddharat C; Champreeda P; Daniels J; Chokephaibulkit K; Wongwan N; Polwichai P
    Southeast Asian J Trop Med Public Health; 2008 May; 39(3):461-6. PubMed ID: 18564685
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy of a new pharmacokinetically enhanced formulation of amoxicillin/clavulanate (2000/125 mg) in adults with community-acquired pneumonia caused by Streptococcus pneumoniae, including penicillin-resistant strains.
    File TM; Garau J; Jacobs MR; Wynne B; Twynholm M; Berkowitz E
    Int J Antimicrob Agents; 2005 Feb; 25(2):110-9. PubMed ID: 15664480
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.